Website Under Maintenance

Newsroom Published Jun 08, 2024 01:50 PM

Our site is down for scheduled maintenance. We are working to update our network to better provide the page you requested. We understand the inconvenience this may cause, but rest assured, we are doing everything we can to bring the site back online after our necessary updates.

Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)

By: Glancy Prongay & Murray LLP via Business Wire

February 15, 2024 at 13:06 PM EST

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of MEI Pharma, Inc. (Nasdaq: MEIP) concerning the Company and its directors’ and officers’ possible violations of state laws.

If you own MEI Pharma stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Tom Kennedy, of GPM, 230 Park Avenue, Suite 358, New York, NY 10169 at tkennedy@glancylaw.com, or at 212-682-5340. If you inquire by email please include your mailing address, telephone number, and the number of shares purchased and held.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240215141307/en/

Contacts

Glancy Prongay & Murray LLP

Tom Kennedy, 212-682-5340

tkennedy@glancylaw.com

www.glancylaw.com

Website Under Maintenance

Website Under Maintenance

Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)

Contacts

More News